Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Hypophosphatasia,covid-19
• Age: Between 0 years - 65 years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Patient must have documented alkaline phosphatase (ALP) activity below the lower limit of normal for age and sex, or a documented ALPL gene mutation.
  2. Patient or parent (or legal guardian) is able to read and/or understand the informed consent and study questionnaires in the local language.
  3. Signed informed consent and medical records release by the patient or parent (or legal guardian). Patient or patient’s parent (or legal guardian) must be willing and able to give written informed consent, and the patient must be willing to give written informed assent, if appropriate and required by local regulations.

  
  

You may not be eligible for this study if the following are true:

• 1. Currently participating in an Alexion-sponsored clinical study. Patients who have concluded participation in an Alexion-sponsored asfotase alfa clinical study or the Phase 1 Study ALXN1850-HPP-101 (an Alexion-sponsored study of ALXN1850 in the US) are eligible to enroll in this Registry, and enrollment in the Registry will not exclude a patient from enrolling in a future clinical study.